Listed on the Taipei Exchange (TPEx), classified under Healthcare. This page collects the company's annual reports and investor conference materials, with files served directly by the Market Observation Post System (MOPS).
Taiwanese listed companies hold investor conferences (法人說明會) to present quarterly results. Presentation decks are filed with MOPS, most in both languages.
本公司受台新證券邀請，舉辦實體法說會，由經營團隊向法人及投資者說明公司研發及展業最新狀況。全球首家獲美國FDA核准超音波電腦輔助診斷(CAD)之創新醫材公司，結合超音波AI技術與臨床專業，已研發4項獲FDA、CE及台灣TFDA認證之高階醫材，包括「安克甲狀偵®」甲狀腺超音波AI檢測及「安克呼止偵®」10分鐘睡眠呼吸中止症檢測系統，大幅提升診斷速度與準確性。 公司以創新AI科技為醫療賦能，研發多項獲國際專利及認證之領先技術，屢獲殊榮。
Agenda as filed by the company, in Chinese only.
Every financial year in the table above links straight to the PDF filed with the Market Observation Post System (MOPS), Taiwan's statutory disclosure platform. 2 years are available in English, within a range covering 2024 to 2025.
Filing an English annual report is only mandatory for larger Taiwanese issuers; smaller companies and those on the Emerging Stock Board file in Chinese. Where no English edition exists this site links the Chinese PDF rather than leaving the year blank, so you can still reach the document.
It is the Taiwanese equivalent of an earnings call or analyst briefing. Listed companies present quarterly results and outlook, and file the presentation deck with MOPS — usually in both Chinese and English. Many also publish a webcast recording.
Taiwanese issuers file quarterly financial reports plus an annual report, and publish monthly revenue figures — a disclosure cadence that is more frequent than Hong Kong or Singapore. Financial years are numbered using the ROC calendar (ROC 114 = 2025); this site shows both.
